We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Courtenay C. Brinckerhoff

Foley Hoag LLP

Results 1 to 5 of 7
Most popular |Most recent


Amneal's IPR Challenge Of The Jazz Xyrem Valproate Patent

USA - April 21 2016 In decisions dated April 12, 2016, the USPTO Patent Trial and Appeal Board (PTAB) denied institution as to claims 1-18 of Jazz's U.S. Patent 8,772...


Jazz Xyrem Valproate Patent Claims Avoid IPR

USA - April 18 2016 The USPTO Patent Trial and Appeal Board (PTAB) decided not to institute inter partes review (IPR) of key claims of Jazz's U.S. Patent 8,772,306...


Amgen Hedges Its Bets With Cross-Petition For Certiorari Of Biosimilar Decision

USA - April 7 2016 Although Amgen originally did not petition the Supreme Court for certiorari to review the first Federal Circuit decision interpreting the BPCIA...


Second Time Is The Charm For Kyle Bass Challenges Of Ampyra Patents

USA - March 29 2016 The USPTO Patent Trial and Appeal Board (PTAB) has decided to institute inter partes review (IPR) proceedings against the Ampyra patents based on the...


Sequenom Throws Diagnositc Method Patents At The Mercy Of The Supreme Court

USA - March 24 2016 It comes as no surprise that Sequenom has filed a petition for certiorari to the Supreme Court, asking the Court to review the Federal Circuit...